Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $260
Forecasting The Future: 4 Analyst Projections For Becton Dickinson
Express News | Piper Sandler Maintains Overweight on Becton Dickinson, Lowers Price Target to $260
Express News | Becton Dickinson and Co - Announces FDA Clearance and Launch of Phasix St Umbilical Hernia Patch
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
Express News | BD : Piper Sandler Cuts Target Price to $260 From $280
BD Unveils HemoSphere Alta Advanced Monitoring Platform With Predictive, AI Based Algorithms
Is Becton, Dickinson and Company (BDX) the Best Dividend Monarch to Invest in Now?
Is Becton Dickinson Gaining or Losing Market Support?
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
BD Receives FDA 510(k) Clearance For Advanced Microbiology Solution
Express News | BD: Receives FDA 510(K) Clearance for BD Phoenix M50 & Bdxpert System on BD Synapsys Informatics Solution
Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $261
Becton Dickinson Analyst Ratings
Citigroup Adjusts Becton Dickinson and Co. Price Target to $270 From $275, Maintains Buy Rating
Barclays Adjusts PT on Becton Dickinson and Co. to $261 From $279, Keeps Overweight Rating
Express News | Baxter Down 5.5%, Abbott Down 2.3%, Becton Dickinson Down 2.9%, Illumina Down 5.3%, Dexcom Down 2.2%, Medtronic Down 2.1%, Stryker Down 3.5%
Express News | Shares of Medical Device Makers Fall Amid Broad Market Selloff